• Home
• Afib Blog
• FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter

FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter

• Medication
• Treatment

Posted on July 2, 2009

By: Mellanie True Hills

BREAKING NEWS

Multaq(R), the much anticipated replacement for amiodarone, just received FDA approval.

Read the press release: FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter

One Response to FDA Approves Multaq® for Patients with Atrial Fibrillation or Atrial Flutter

• Don Lajoie says:

  July 27, 2009 at 11:50 am

  Does anyone have an estimate of timing on approvals for Multaq in Canada now that the FDA has approved?

  Reply